In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.

A 2022 study of 127 people found that GLP-1 drug exenatide ... Researchers not involved in the study cautioned it does not ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

The new weight-loss drugs have created “a hope and optimism ... by at least 5 percent in most participants after 56 weeks. A 2022 trial of 201 teens aged 12 to 18 reported a higher treatment ...

As revenues fall in diabetes treatments, has the industry found a new revenue driver in weight-loss treatments ... the FDA for type 2 diabetes in May 2022, and, ahead of any additional approval ...

On Tuesday, a Cantor analyst wrote that additional data from Amgen’s experimental weight loss injection, MariTide, suggests a ...

Prescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled between 2022 and 2023, a new ...